Top image

The Cancer Institute of NSW announces grant recipients

Article Type
News Articles
13 March 2018

The Cancer Institute of NSW (CINSW) announced over $12m in grant funding over the weekend. This boost in cancer research supports many of Sydney Catalyst members and their translational research efforts and we would like to take this opportunity to say congratulations. 

The research will improve the lives and outcomes of patients across the state. The centrepiece is a $3.75 million Translational Program Grant, helping Professor Lisa Hovarth and her team continue to integrate prostate cancer research into clinical practice over the next five years. This TPG was formally endorsed and supported by Sydney Catalyst and we're incredibly glad to see Lisa and her team's work receive this recognition and funding. Congratulations! 

Professor Hovarth is a long standing member of Sydney Catalyst Members, who makes a valuable contribution as part of our Scientific Advisory Committee and T1/T2 Working group. 

CINSW identified that "The grant will help develop improved imaging techniques to better determine which early stage prostate cancers will become life-threatening and need aggressive treatments."

Click here to read the full news announcement from CINSW 


We would also like to congratulate the following members whose funding through other CINSW schemes was announced at the same time, including:

Early Career Fellowships:

  • Dr David Herrman, Garvan Institute of Medical Research
  • Dr Max Nobis, Garvan Institute of Medical Research
  • Dr Alexander Menzies, The University of Sydney
  • Dr Ulf Schmitz, The University of Sydney


Career Development Fellowships

  • Dr Thomas Cox, Garvan Institute of Medical Research
  • Dr Patric Jansson, The University of Sydney
  • Dr Zaklina Kovacevic, The University of Sydney
  • Dr Justin Jong-Leong Wong, The University of Sydney


We love hearing about our members' achievements. Please get in touch at anytime and tell us how your research is progressing.

Back to list